Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ: AMRX · IEX Real-Time Price · USD
5.80
+0.11 (1.93%)
At close: Feb 23, 2024, 4:00 PM
5.72
-0.08 (-1.38%)
After-hours: Feb 23, 2024, 7:48 PM EST

Total Valuation

AMRX has a market cap or net worth of $1.78 billion. The enterprise value is $4.49 billion.

Market Cap 1.78B
Enterprise Value 4.49B

Important Dates

The next confirmed earnings date is Friday, March 1, 2024, before market open.

Earnings Date Mar 1, 2024
Ex-Dividend Date n/a

Share Statistics

AMRX has 306.54 million shares outstanding. The number of shares has increased by 5.48% in one year.

Shares Outstanding 306.54M
Shares Change (YoY) +5.48%
Shares Change (QoQ) +3.10%
Owned by Insiders (%) 53.05%
Owned by Institutions (%) 36.11%
Float 122.34M

Valuation Ratios

The trailing PE ratio is 96.67 and the forward PE ratio is 14.03.

PE Ratio 96.67
Forward PE 14.03
PS Ratio 0.75
Forward PS 0.71
PB Ratio 5.37
P/FCF Ratio 12.70
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.23, with an EV/FCF ratio of 32.05.

EV / Earnings 434.66
EV / Sales 1.88
EV / EBITDA 10.23
EV / EBIT 21.87
EV / FCF 32.05

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 8.48.

Current Ratio 1.91
Quick Ratio 1.04
Debt / Equity 8.48
Debt / EBITDA 6.39
Debt / FCF 20.04
Interest Coverage 1.04

Financial Efficiency

Return on equity (ROE) is 3.30% and return on invested capital (ROIC) is 10.56%.

Return on Equity (ROE) 3.30%
Return on Assets (ROA) 0.30%
Return on Capital (ROIC) 10.56%
Revenue Per Employee $313,998
Profits Per Employee $1,358
Employee Count 7,600
Asset Turnover 0.64
Inventory Turnover 2.75

Taxes

Income Tax -3.23M
Effective Tax Rate -45.50%

Stock Price Statistics

The stock price has increased by +160.09% in the last 52 weeks. The beta is 1.34, so AMRX's price volatility has been higher than the market average.

Beta (1Y) 1.34
52-Week Price Change +160.09%
50-Day Moving Average 5.57
200-Day Moving Average 4.07
Relative Strength Index (RSI) 56.06
Average Volume (30 Days) 1,372,501

Short Selling Information

The latest short interest is 2.54 million, so 0.83% of the outstanding shares have been sold short.

Short Interest 2.54M
Short Previous Month 2.52M
Short % of Shares Out 0.83%
Short % of Float 2.08%
Short Ratio (days to cover) 1.76

Income Statement

In the last 12 months, AMRX had revenue of $2.39 billion and earned $10.32 million in profits. Earnings per share was $0.06.

Revenue 2.39B
Gross Profit 846.13M
Operating Income 227.65M
Pretax Income 7.10M
Net Income 10.32M
EBITDA 438.73M
EBIT 205.20M
Earnings Per Share (EPS) $0.06
Full Income Statement

Balance Sheet

The company has $95.61 million in cash and $2.80 billion in debt, giving a net cash position of -$2.71 billion or -$8.84 per share.

Cash & Cash Equivalents 95.61M
Total Debt 2.80B
Net Cash -2.71B
Net Cash Per Share -$8.84
Equity / Book Value 330.86M
Book Value Per Share 1.08
Working Capital 695.47M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $186.46 million and capital expenditures -$46.48 million, giving a free cash flow of $139.99 million.

Operating Cash Flow 186.46M
Capital Expenditures -46.48M
Free Cash Flow 139.99M
FCF Per Share $0.91
Full Cash Flow Statement

Margins

Gross margin is 35.46%, with operating and profit margins of 9.54% and 0.43%.

Gross Margin 35.46%
Operating Margin 9.54%
Pretax Margin 0.30%
Profit Margin 0.43%
EBITDA Margin 18.38%
EBIT Margin 8.60%
FCF Margin 5.87%

Dividends & Yields

AMRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.48%
Shareholder Yield -5.48%
Earnings Yield 0.58%
FCF Yield 7.87%
Dividend Details

Analyst Forecast

The average price target for AMRX is $5.40, which is -6.90% lower than the current price. The consensus rating is "Strong Buy".

Price Target $5.40
Price Target Difference -6.90%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 3.42%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AMRX has an Altman Z-Score of 1.21 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.21
Piotroski F-Score 8